Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan | PLOS ONE
![Pharmaceutics | Free Full-Text | Can Essential Oils/Botanical Agents Smart-Nanoformulations Be the Winning Cards against Psoriasis? Pharmaceutics | Free Full-Text | Can Essential Oils/Botanical Agents Smart-Nanoformulations Be the Winning Cards against Psoriasis?](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-00750/article_deploy/html/images/pharmaceutics-15-00750-ag.png?1677158711)
Pharmaceutics | Free Full-Text | Can Essential Oils/Botanical Agents Smart-Nanoformulations Be the Winning Cards against Psoriasis?
![Bristol Myers Squibb - U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis Bristol Myers Squibb - U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis](https://s25.q4cdn.com/566753351/files/doc_multimedia/Deucrava_US_Approval_Product_Shots.jpg)
Bristol Myers Squibb - U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis
![JCM | Free Full-Text | Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland JCM | Free Full-Text | Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland](https://www.mdpi.com/jcm/jcm-12-01675/article_deploy/html/images/jcm-12-01675-g001.png)
JCM | Free Full-Text | Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland
![Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients | Semantic Scholar Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2cf5faab122da1e296eccd364de1c72a69e2ab1e/2-Figure1-1.png)
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients | Semantic Scholar
![Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis | SpringerLink Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-021-00654-1/MediaObjects/13555_2021_654_Fig1_HTML.png)
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis | SpringerLink
![Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin | Scientific Reports Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65689-4/MediaObjects/41598_2020_65689_Fig1_HTML.png)
Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin | Scientific Reports
![Multi-modality data-driven analysis of diagnosis and treatment of psoriatic arthritis | npj Digital Medicine Multi-modality data-driven analysis of diagnosis and treatment of psoriatic arthritis | npj Digital Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41746-023-00757-3/MediaObjects/41746_2023_757_Fig1_HTML.png)
Multi-modality data-driven analysis of diagnosis and treatment of psoriatic arthritis | npj Digital Medicine
![Distributions of demographic characteristics of 1089 control and 410... | Download Scientific Diagram Distributions of demographic characteristics of 1089 control and 410... | Download Scientific Diagram](https://www.researchgate.net/publication/355274748/figure/tbl1/AS:1081547750940673@1634872486584/Distributions-of-demographic-characteristics-of-1089-control-and-410-patients-with.png)
Distributions of demographic characteristics of 1089 control and 410... | Download Scientific Diagram
![Clinical and immunohistochemical respons after treatment with a CCR5... | Download Scientific Diagram Clinical and immunohistochemical respons after treatment with a CCR5... | Download Scientific Diagram](https://www.researchgate.net/profile/Marcel-Teunissen/publication/6191704/figure/fig2/AS:394707399135254@1471116985454/Clinical-and-immunohistochemical-respons-after-treatment-with-a-CCR5-receptor-inhibitor_Q320.jpg)
Clinical and immunohistochemical respons after treatment with a CCR5... | Download Scientific Diagram
![PASI scores for patients with PsV and patients with PsA. Percentage of... | Download Scientific Diagram PASI scores for patients with PsV and patients with PsA. Percentage of... | Download Scientific Diagram](https://www.researchgate.net/publication/301764051/figure/fig2/AS:615058593820672@1523652804122/PASI-scores-for-patients-with-PsV-and-patients-with-PsA-Percentage-of-patients-with-PASI.png)
PASI scores for patients with PsV and patients with PsA. Percentage of... | Download Scientific Diagram
![File:1864 Garnier Map of Pairs, France w-Monuments - Geographicus - Paris-garnier-1864.jpg - Wikimedia Commons File:1864 Garnier Map of Pairs, France w-Monuments - Geographicus - Paris-garnier-1864.jpg - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/thumb/5/51/1864_Garnier_Map_of_Pairs%2C_France_w-Monuments_-_Geographicus_-_Paris-garnier-1864.jpg/2560px-1864_Garnier_Map_of_Pairs%2C_France_w-Monuments_-_Geographicus_-_Paris-garnier-1864.jpg)